Skip to main content

Table 2 Results of Decision Model and Sensitivity Analyses

From: Daily almond consumption in cardiovascular disease prevention via LDL-C change in the U.S. population: a cost-effectiveness analysis

 Cost
($)
ΔC
($)
Outcome (QALYs)ΔE (QALYs)C/E
($/QALY)
ICER
($/QALY)
NMB
($)
Decision model
WTP = $50,000
 Non-almond1524Ref0.94Ref1625Dominated45,373
 Almond1161−3630.960.021211 46,794
WTP = $100,000
 Non-almond1524Ref0.94Ref1625Dominated92,270
 Almond1161−3630.960.021211 94,749
WTP = $200,000
 Non-almond1524Ref0.94Ref1625Dominated186,064
 Almond1161−3630.960.021211 190,658
Sensitivity–Probabilistic Sensitivity Analysis
 Non-almond1555 ± 59Ref0.94 ± 0.0005Ref1658 ± 63 45,333 ± 84
 Almond1589 ± 41734 ± 4140.94 ± 0.020.005 ± 0.021694 ± 474−26,798 ± 814,51445,542 ± 1245
Sensitivity–10-year model
 Non-almond20,871Ref8.13Ref2566Dominated385,788
 Almond15,120−57508.370.241806 403,377
Sensitivity–cost of procedure
 Non-almond1524Ref0.94Ref1625Dominated45,373
 Almond1161−3630.960.021210 46,794
Sensitivity–cost of almond
 Non-almond1524Ref0.94Ref1625Dominated45,373
 Higher cost of almond1474−500.960.021537 46,480
Sensitivity–CVD patients
 Non-almond1213Ref0.86Ref1411Dominated41,766
 Almond1022−1900.860.00011189 41,962
  1. Abbreviations: C/E cost-effectiveness ratio, ICER incremental cost-effectiveness ratio, NMB net monetary benefit, QALY quality-adjusted life years, WTP willingness-to-pay